Biotechnology company Anixa Biosciences, partnered by IT and pharma solutions company OntoChem, has announced that it will enter the next stage of development of its potential anti-viral therapy The post Anixa and OntoChem enter next stage of Covid-19 anti-viral therapy development appeared first on Pharmaceutical Business review. … [Read more...]

French pharmaceutical company AB Science has signed an exclusive licensing agreement with the University of Chicago to conduct research for the prevention and treatment of Covid-19 with masitinib The post AB Science and University of Chicago to conduct Covid-19 treatment research appeared first on Pharmaceutical Business review. … [Read more...]

The US Food and Drug Administration (FDA) has extended the review period for AbbVie’s supplemental New Drug Application (sNDA) for Rinvoq (upadacitinib). Rinvoq, which is discovered and developed The post AbbVie announces extension of USFDA review period for Rinvoq sNDA appeared first on Pharmaceutical Business review. … [Read more...]

Antengene has announced that China’s National Medical Products Administration (NMPA) has given approval to investigational new drug (IND) application for Phase I clinical trials of ATG-019 (monotherapy or The post Antengene announces China’s NMPA approval for IND application for ATG-019 clinical trial appeared first on Pharmaceutical Business review. … [Read more...]